Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome

TY - JOUR

T1 - Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome

AU - Kofoed, Peter Kristian

AU - Munch, Inger Christine

AU - Larsen, Michael

N1 - © 2009 The Authors. Journal compilation © 2009 Acta Ophthalmol.

PY - 2009

Y1 - 2009

N2 - Abstract. Purpose: To report the result of ranibizumab administration in an eye with ocular ischaemic syndrome. Methods: Fluorescein angiography, ocular pneumoplethysmography and retinal vessel calibre measurement. Results: An 85-year-old man with ocular ischaemic syndrome demonstrated vision loss, retinal vessel calibre constriction and profound retinal ischaemia after intravitreal ranibizumab. Conclusion: We advise against the use of intravitreal vascular endothelial growth factor inhibitors in eyes with ocular ischaemic syndrome.

AB - Abstract. Purpose: To report the result of ranibizumab administration in an eye with ocular ischaemic syndrome. Methods: Fluorescein angiography, ocular pneumoplethysmography and retinal vessel calibre measurement. Results: An 85-year-old man with ocular ischaemic syndrome demonstrated vision loss, retinal vessel calibre constriction and profound retinal ischaemia after intravitreal ranibizumab. Conclusion: We advise against the use of intravitreal vascular endothelial growth factor inhibitors in eyes with ocular ischaemic syndrome.

U2 - 10.1111/j.1755-3768.2009.01612.x

DO - 10.1111/j.1755-3768.2009.01612.x

M3 - Journal article

C2 - 19832734

SN - 1755-375X

VL - 88

SP - 808

EP - 810

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 7

ER -